Pfizer: EUA vaccine application could be ready by late November

Pfizer said on Friday it may file for authorization of the Covid-19 vaccine it is developing with German partner BioNTech in late November, making it unlikely a vaccine will be available before U.S. elections as President Donald Trump has promised. Separately, a study coordinated by the World Health Organization has indicated that remdesivir, along with three other potential drug treatments for the coronavirus, has “little or no effect” on death rates among hospitalized patients. CNBC's Meg Tirrell reports.
Fri, Oct 16 20209:50 AM EDT